- Home
- GDEN vs FTRE Comparison
GDEN vs FTRE Comparison
Compare GDEN & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDEN | FTRE |
|---|---|---|
| Founded | N/A | 1996 |
| Country | United States | United States |
| Employees | 504 | N/A |
| Industry | Services-Misc. Amusement & Recreation | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 763.2M | 829.3M |
| IPO Year | 1998 | 2023 |
Fundamental Metrics
Financial Performance| Metric | GDEN | FTRE |
|---|---|---|
| Price | $27.12 | $8.99 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $32.25 | $15.39 |
| AVG Volume (30 Days) | 116.5K | ★ 1.2M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.70% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $634,911,000.00 | ★ $2,723,400,000.00 |
| Revenue This Year | $5.17 | N/A |
| Revenue Next Year | $2.85 | $3.01 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 1.00 |
| 52 Week Low | $19.57 | $3.97 |
| 52 Week High | $32.74 | $18.67 |
Technical Indicators
Market Signals| Indicator | GDEN | FTRE |
|---|---|---|
| Relative Strength Index (RSI) | 48.31 | 38.52 |
| Support Level | $26.73 | $8.85 |
| Resistance Level | $27.95 | $11.22 |
| Average True Range (ATR) | 0.48 | 0.64 |
| MACD | 0.05 | 0.13 |
| Stochastic Oscillator | 57.75 | 30.43 |
Price Performance
Historical ComparisonAbout GDEN Golden Entertainment Inc.
Golden Entertainment Inc is a U.S. based company that focuses on distributed gaming, casino, and resort operations. Its reportable segments are Nevada Casino Resorts, Nevada Locals Casinos, Nevada Taverns, and Distributed Gaming. The majority of the revenue for the company is generated from its Nevada Casino Resorts segment which is comprised of destination casino resort properties offering a variety of food and beverage outlets, entertainment venues, and other amenities.
About FTRE Fortrea Holdings Inc.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.